US Stock MarketDetailed Quotes

CDT Conduit Pharmaceuticals

Watchlist
  • 0.076
  • +0.007+10.35%
Close Jan 2 16:00 ET
  • 0.078
  • +0.002+2.38%
Post 20:01 ET
9.07MMarket Cap-0.40P/E (TTM)

Conduit Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
1,251.40%5.81M
253.60%3.14M
95.05%2.96M
66.52%5.26M
45.10%2.43M
-53.91%430K
888K
420.62%1.52M
-0.41%3.16M
1.67M
Selling and administrative expenses
532.09%2.72M
250.79%3.12M
86.60%2.83M
69.63%5.17M
35.91%2.34M
-44.52%430K
--888K
420.62%1.52M
5.50%3.05M
--1.72M
-General and administrative expense
532.09%2.72M
250.79%3.12M
86.60%2.83M
69.63%5.17M
35.91%2.34M
-44.52%430K
--888K
420.62%1.52M
5.50%3.05M
--1.72M
Research and development costs
--3.09M
--25K
--128K
-18.92%90K
291.49%90K
--0
--0
--0
-60.78%111K
---47K
Operating profit
-1,251.40%-5.81M
-253.60%-3.14M
-95.05%-2.96M
-66.52%-5.26M
-45.10%-2.43M
53.91%-430K
-888K
-420.62%-1.52M
0.41%-3.16M
-1.67M
Net non-operating interest income expense
-310K
-200.00%-117K
-110K
-392K
-306K
0
-39K
0
0
0
Non-operating interest income
--0
--2K
--9K
--30K
--30K
--0
--0
--0
--0
----
Non-operating interest expense
--167K
205.13%119K
--119K
--422K
--336K
--0
--39K
--0
--0
--0
Total other finance cost
--143K
----
----
----
----
----
----
----
----
----
Other net income (expense)
-111.13%-340K
-164.10%-2.13M
-210.19%-487K
396.41%5.12M
313.31%2.98M
13,382.61%3.06M
-805K
-881.25%-157K
-256.82%-1.73M
-1.4M
Gain on sale of security
-98.22%58K
110.74%84K
----
458.00%5.23M
--2.65M
--3.26M
---782K
----
-255.72%-1.46M
----
Special income (charges)
---393K
----
----
----
----
--0
----
----
----
----
-Less:Restructuring and merger&acquisition
--393K
----
----
----
----
--0
----
----
----
----
Other non- operating income (expenses)
97.56%-5K
-9,508.70%-2.21M
-210.19%-487K
56.60%-115K
403.08%327K
-791.30%-205K
---23K
-15,600.00%-157K
-263.01%-265K
--65K
Income before tax
-346.13%-6.46M
-210.80%-5.38M
-112.44%-3.55M
89.05%-535K
107.98%245K
374.58%2.63M
-1.73M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
Income tax
Net income
-346.13%-6.46M
-210.80%-5.38M
-112.44%-3.55M
89.05%-535K
107.98%245K
374.58%2.63M
-1.73M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
Net income continuous Operations
-346.13%-6.46M
-210.80%-5.38M
-112.44%-3.55M
89.05%-535K
107.98%245K
374.58%2.63M
---1.73M
-444.63%-1.67M
-33.63%-4.89M
---3.07M
Minority interest income
Net income attributable to the parent company
-346.13%-6.46M
-210.62%-5.38M
-112.44%-3.55M
89.05%-535K
107.98%245K
374.58%2.63M
-1.73M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-346.13%-6.46M
-210.62%-5.38M
-112.44%-3.55M
89.05%-535K
107.98%245K
374.58%2.63M
-1.73M
-444.63%-1.67M
-33.63%-4.89M
-3.07M
Basic earnings per share
-275.00%-0.07
-192.52%-0.07
-116.56%-0.05
85.18%-0.01
0
403.01%0.04
-0.0239
-444.66%-0.0231
-33.63%-0.0675
-0.0424
Diluted earnings per share
-800.00%-0.07
-192.52%-0.07
-116.56%-0.05
-33.37%-0.09
29.26%-0.03
175.75%0.01
-0.0239
-444.66%-0.0231
-33.63%-0.0675
-0.0424
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 1,251.40%5.81M253.60%3.14M95.05%2.96M66.52%5.26M45.10%2.43M-53.91%430K888K420.62%1.52M-0.41%3.16M1.67M
Selling and administrative expenses 532.09%2.72M250.79%3.12M86.60%2.83M69.63%5.17M35.91%2.34M-44.52%430K--888K420.62%1.52M5.50%3.05M--1.72M
-General and administrative expense 532.09%2.72M250.79%3.12M86.60%2.83M69.63%5.17M35.91%2.34M-44.52%430K--888K420.62%1.52M5.50%3.05M--1.72M
Research and development costs --3.09M--25K--128K-18.92%90K291.49%90K--0--0--0-60.78%111K---47K
Operating profit -1,251.40%-5.81M-253.60%-3.14M-95.05%-2.96M-66.52%-5.26M-45.10%-2.43M53.91%-430K-888K-420.62%-1.52M0.41%-3.16M-1.67M
Net non-operating interest income expense -310K-200.00%-117K-110K-392K-306K0-39K000
Non-operating interest income --0--2K--9K--30K--30K--0--0--0--0----
Non-operating interest expense --167K205.13%119K--119K--422K--336K--0--39K--0--0--0
Total other finance cost --143K------------------------------------
Other net income (expense) -111.13%-340K-164.10%-2.13M-210.19%-487K396.41%5.12M313.31%2.98M13,382.61%3.06M-805K-881.25%-157K-256.82%-1.73M-1.4M
Gain on sale of security -98.22%58K110.74%84K----458.00%5.23M--2.65M--3.26M---782K-----255.72%-1.46M----
Special income (charges) ---393K------------------0----------------
-Less:Restructuring and merger&acquisition --393K------------------0----------------
Other non- operating income (expenses) 97.56%-5K-9,508.70%-2.21M-210.19%-487K56.60%-115K403.08%327K-791.30%-205K---23K-15,600.00%-157K-263.01%-265K--65K
Income before tax -346.13%-6.46M-210.80%-5.38M-112.44%-3.55M89.05%-535K107.98%245K374.58%2.63M-1.73M-444.63%-1.67M-33.63%-4.89M-3.07M
Income tax
Net income -346.13%-6.46M-210.80%-5.38M-112.44%-3.55M89.05%-535K107.98%245K374.58%2.63M-1.73M-444.63%-1.67M-33.63%-4.89M-3.07M
Net income continuous Operations -346.13%-6.46M-210.80%-5.38M-112.44%-3.55M89.05%-535K107.98%245K374.58%2.63M---1.73M-444.63%-1.67M-33.63%-4.89M---3.07M
Minority interest income
Net income attributable to the parent company -346.13%-6.46M-210.62%-5.38M-112.44%-3.55M89.05%-535K107.98%245K374.58%2.63M-1.73M-444.63%-1.67M-33.63%-4.89M-3.07M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -346.13%-6.46M-210.62%-5.38M-112.44%-3.55M89.05%-535K107.98%245K374.58%2.63M-1.73M-444.63%-1.67M-33.63%-4.89M-3.07M
Basic earnings per share -275.00%-0.07-192.52%-0.07-116.56%-0.0585.18%-0.010403.01%0.04-0.0239-444.66%-0.0231-33.63%-0.0675-0.0424
Diluted earnings per share -800.00%-0.07-192.52%-0.07-116.56%-0.05-33.37%-0.0929.26%-0.03175.75%0.01-0.0239-444.66%-0.0231-33.63%-0.0675-0.0424
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data